| Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit. | |
| | |
MedLine Citation:
|
PMID: 21942611 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Evidence-based indications for the use of plasma products in neonatal medicine are limited to few conditions. In the setting of inherited disorders of hemostasis, fresh frozen plasma (FFP) and cryoprecipitate should be used as replacement therapy only if the specific factor concentrate is not available. FFP is indicated to treat disseminated intravascular coagulation (DIC), liver failure, vitamin K-dependent bleeding and to reconstitute whole blood for exchange transfusion. Despite the lack of evidence, the use of cryoprecipitate to treat neonates with acquired hypofibrinogenemia during DIC or liver failure is now considered standard therapy. |
| | |
Authors:
|
Mario Motta; Antonello Del Vecchio; Maurizio Radicioni |
Publication Detail:
|
Type: JOURNAL ARTICLE |
Journal Detail:
|
Title: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians Volume: 24 ISSN: 1476-4954 ISO Abbreviation: - Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-9-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101136916 Medline TA: J Matern Fetal Neonatal Med Country: - |
Other Details:
|
Languages: ENG Pagination: 129-131 Citation Subset: - |
Affiliation:
|
Neonatal Intensive Care Unit, Children's Hospital of Brescia , Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Transport as a system: reorganization of perinatal assistance in Northern Lombardy.
Next Document: First year follow-up of extremely low birth weight premature sextuplets: case report.